Cargando…
Effect of anticoagulant therapy in COVID-19 patients
BACKGROUND: In patients hospitalised with COVID-19, an increased incidence of thromboembolic events, such as pulmonary embolism, deep vein thrombosis and stroke, has been reported. It is unknown whether anticoagulation can prevent these complications and improve outcome. METHODS: A systematic litera...
Autores principales: | Tieleman, R. G., Klok, F. A., Belfroid, E., Hoogervorst-Schilp, J., Schalkers, I., Jansen, C. W., Siebelink, H. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bohn Stafleu van Loghum
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8050812/ https://www.ncbi.nlm.nih.gov/pubmed/33861430 http://dx.doi.org/10.1007/s12471-021-01574-7 |
Ejemplares similares
-
Impact of cardiovascular disease and cardiovascular risk factors in hospitalised COVID-19 patients
por: Jewbali, L. S. D., et al.
Publicado: (2021) -
The effects of ACE2 expression mediating pharmacotherapy in COVID-19 patients
por: van Kimmenade, R. R. J., et al.
Publicado: (2021) -
How often and to what extent do admitted COVID-19 patients have signs of cardiac injury?
por: Habets, M. A. W., et al.
Publicado: (2021) -
Four guidelines on cardiovascular complications and cardiovascular disease, prognosis and treatment in COVID‑19
por: Siebelink, H. J., et al.
Publicado: (2021) -
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines
por: Veitch, Andrew M, et al.
Publicado: (2016)